Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 22, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 22, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $524.27 ($62,912) on July 22, 2026; holds 333,823 after (Indirect).
- Open-market sale: disposed of 485 Common Stock at $526.04 ($255,131) on July 22, 2026; holds 333,338 after (Indirect).
- Open-market sale: disposed of 2,610 Common Stock at $526.84 ($1,375,058) on July 22, 2026; holds 330,728 after (Indirect).
- Open-market sale: disposed of 1,211 Common Stock at $527.82 ($639,189) on July 22, 2026; holds 329,517 after (Indirect).
- Open-market sale: disposed of 874 Common Stock at $528.91 ($462,265) on July 22, 2026; holds 328,643 after (Indirect).
- Open-market sale: disposed of 760 Common Stock at $529.80 ($402,644) on July 22, 2026; holds 327,883 after (Indirect).
- Open-market sale: disposed of 400 Common Stock at $531.22 ($212,490) on July 22, 2026; holds 327,483 after (Indirect).
- Open-market sale: disposed of 489 Common Stock at $533.24 ($260,756) on July 22, 2026; holds 326,994 after (Indirect).
- Open-market sale: disposed of 324 Common Stock at $534.18 ($173,076) on July 22, 2026; holds 326,670 after (Indirect).
- Open-market sale: disposed of 107 Common Stock at $535.40 ($57,288) on July 22, 2026; holds 326,563 after (Indirect).
- Open-market sale: disposed of 790 Common Stock at $536.49 ($423,827) on July 22, 2026; holds 325,773 after (Indirect).
- Open-market sale: disposed of 570 Common Stock at $537.60 ($306,434) on July 22, 2026; holds 325,203 after (Indirect).
- Open-market sale: disposed of 680 Common Stock at $538.46 ($366,153) on July 22, 2026; holds 324,523 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $539.47 ($43,158) on July 22, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 22, 2026; holds 293,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,040,380 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-07-22 | Open-market sale | Common Stock | 120 | $524 | $62.9K | 333,823 |
| 2026-07-22 | Open-market sale | Common Stock | 485 | $526 | $255.1K | 333,338 |
| 2026-07-22 | Open-market sale | Common Stock | 2,610 | $527 | $1.4M | 330,728 |
| 2026-07-22 | Open-market sale | Common Stock | 1,211 | $528 | $639.2K | 329,517 |
| 2026-07-22 | Open-market sale | Common Stock | 874 | $529 | $462.3K | 328,643 |
| 2026-07-22 | Open-market sale | Common Stock | 760 | $530 | $402.6K | 327,883 |
| 2026-07-22 | Open-market sale | Common Stock | 400 | $531 | $212.5K | 327,483 |
| 2026-07-22 | Open-market sale | Common Stock | 489 | $533 | $260.8K | 326,994 |
| 2026-07-22 | Open-market sale | Common Stock | 324 | $534 | $173.1K | 326,670 |
| 2026-07-22 | Open-market sale | Common Stock | 107 | $535 | $57.3K | 326,563 |
| 2026-07-22 | Open-market sale | Common Stock | 790 | $536 | $423.8K | 325,773 |
| 2026-07-22 | Open-market sale | Common Stock | 570 | $538 | $306.4K | 325,203 |
| 2026-07-22 | Open-market sale | Common Stock | 680 | $538 | $366.2K | 324,523 |
| 2026-07-22 | Open-market sale | Common Stock | 80 | $539 | $43.2K | 324,443 |
| 2026-07-22 | Option exercise/conversion | Stock Option | 9,500 | — | — | 293,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Option exercise/conversion (9,500 shares) |
| 2026-07-22 | Open-market sale (120 shares) |
| 2026-07-22 | Open-market sale (485 shares) |
| 2026-07-22 | Open-market sale (2,610 shares) |
| 2026-07-22 | Open-market sale (1,211 shares) |
| 2026-07-22 | Open-market sale (874 shares) |
| 2026-07-22 | Open-market sale (760 shares) |
| 2026-07-22 | Open-market sale (400 shares) |
| 2026-07-22 | Open-market sale (489 shares) |
| 2026-07-22 | Open-market sale (324 shares) |
| 2026-07-22 | Open-market sale (107 shares) |
| 2026-07-22 | Open-market sale (790 shares) |
| 2026-07-22 | Open-market sale (570 shares) |
| 2026-07-22 | Open-market sale (680 shares) |
| 2026-07-22 | Open-market sale (80 shares) |
| 2026-07-22 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.